Current Size: 100%
Cancer incidence in Irish kidney transplant recipients

With the advent of immunosuppressive treatments, the number of people eligible for kidney transplant has increased in recent years, as have survival rates after transplantation among renal transplant recipients (RTRs). It is known that skin cancer rates are elevated among recipients. Therefore, in an ever-changing clinical environment, a method of monitoring skin cancer rates is required. Renal transplant recipient databases in both Northern Ireland (NI) and the Republic of Ireland (ROI) were linked to their respective cancer registries for diagnosis of non-melanoma skin cancer (NMSC), squamous cell carcinoma (SCC) of the skin, and basal cell carcinoma (BCC).
A modelling approaching has been adopted to estimate the age-specific trends in non-melanoma skin cancer rates that adjust appropriately for the changing recipient population over time, in terms of their sex and age structure, but also the length of time post-transplant, and background population incidence rates.
- Bladder cancer in renal allograft recipients: risk factors and outcomes
- Surveillance of Nonmelanoma Skin Cancer Incidence Rates in Kidney Transplant Recipients in Ireland
- Malignant melanoma in renal transplant recipients
- The role of immunosuppression in the pathogenesis of basal cell carcinoma
- A population-based study of skin cancer incidence and prevalence in renal transplant recipients


